Nitric oxide inhibits heterologous CFTR expression in polarized epithelial cells
Open Access
- 1 July 1999
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 277 (1) , L89-L96
- https://doi.org/10.1152/ajplung.1999.277.1.l89
Abstract
Nitric oxide (⋅ NO) has been implicated in a wide range of autocrine and paracrine signaling mechanisms. Herein, we assessed the role of exogenous ⋅ NO in the modulation of heterologous gene expression in polarized kidney epithelial cells (LLC-PK1) that were stably transduced with a cDNA encoding human wild-type cystic fibrosis transmembrane conductance regulator (CFTR) under the control of a heavy metal-sensitive metallothionein promoter (LLC-PK1-WTCFTR). Exposure of these cells to 125 μM DETA NONOate at 37°C for 24 h (a chemical ⋅ NO donor) diminished Zn2+-induced and uninduced CFTR protein levels by 43.3 ± 5.1 and 34.4 ± 17.1% from their corresponding control values, respectively. These changes did not occur if red blood cells, effective scavengers of ⋅ NO, were added to the medium. Exposure to ⋅ NO did not alter lactate dehydrogenase release in the medium or the extent of apoptosis. Coculturing LLC-PK1-WTCFTR cells with murine fibroblasts that were stably transduced with the human inducible ⋅ NO synthase cDNA gene also inhibited CFTR protein expression in a manner that was antagonized by 1 mM NG-monomethyl-l-arginine in the medium. Pretreatment of LLC-PK1-WTCFTR with ODQ, an inhibitor of guanylyl cyclase, did not affect the ability of ⋅ NO to inhibit heterologous CFTR expression; furthermore, 8-bromo-cGMP had no effect on heterologous CFTR expression. These data indicate that ⋅ NO impairs the heterologous expression of CFTR in epithelial cells at the protein level via cGMP-independent mechanisms.Keywords
This publication has 36 references indexed in Scilit:
- Nitrite levels in breath condensate of patients with cystic fibrosis is elevated in contrast to exhaled nitric oxideThorax, 1998
- Inhibition of NF-κB and HIV-1 Long Terminal Repeat Transcriptional Activation by Inducible Nitric Oxide Synthase 2 ActivityJournal of Biological Chemistry, 1998
- Interferon gamma and interleukin 4 stimulate prolonged expression of inducible nitric oxide synthase in human airway epithelium through synthesis of soluble mediators.Journal of Clinical Investigation, 1997
- Anti-T Cell Receptor Antibody Prolongs Transgene Expression and Reduces Lung Inflammation after Adenovirus-Mediated Gene TransferHuman Gene Therapy, 1997
- Characterization of Factors Involved in Modulating Persistence of Transgene Expression from Recombinant Adenovirus in the Mouse LungHuman Gene Therapy, 1997
- Tumor Necrosis Factor α Induces the Adenovirus Early 3 Promoter by Activation of NF-κBPublished by Elsevier ,1996
- Novel guanylyl cyclase inhibitor, ODQ reveals role of nitric oxide, but not of cyclic GMP in endothelin‐1 secretionFEBS Letters, 1995
- Nitric Oxide Inhibits Macrophage-Colony Stimulating Factor Gene Transcription in Vascular Endothelial CellsJournal of Biological Chemistry, 1995
- Nitric Oxide (NO) Donor MoleculesJournal of Cardiovascular Pharmacology, 1995
- Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cellsNature, 1990